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Introduction: Intramuscular myxoma is a rare benign mesenchymal tumor. Myxomas most commonly occur in the
heart. They may occur less frequently in aponeurotic tissues, bone, genitourinary tract, subcutaneous tissue and
skin.
Case presentation: The case described here is a 44-year-old Turkish woman who presented with the complaint of
a swelling in her right shoulder. A preoperative magnetic resonance imaging revealed a lobular contoured mass
lesion in her deltoid muscle. The mass was marginally excised and pathology revealed intramuscular myxoma.
Conclusion: Intramuscular myxoma of the deltoid muscle is a very rare benign tumor. In the differential diagnosis,
reactive lesions, myxoid nodular fasciitis and low -grade myxoid sarcomas should be kept in mind, upon which the
treatment should be planned.
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Myxomas have been described as a true neoplasm of
low-vascularity composed of undifferentiated satellite
cells embedded in myxoid stroma containing collagen
and reticular fibers [1]. Myxoma is the most common
intracardiac (atrial) tumor [2]. Extracardiac myxomas
may occur in aponeurotic tissues, bone, genitourinary
tract, skin, retroperitoneum, intestine, pharynx, joints
and skeletal muscles [1]. Osseous myxomas have been
reported in the jawbones and calcaneum [3]. Extracar-
diac myxomas are benign tumors with a slow growth
rate and low mitotic activity, which are surrounded by
skeletal muscles; they usually present in the 4th to 6th
decades of life in women [4-7].
Intramuscular myxoma usually occurs as an isolated
lesion. The first case of intramuscular myxoma was de-
scribed in 1965 [8]. Intramuscular myxoma rarely occurs
as multiple lesions associated with fibrous dysplasia of
the bone (Mazabraud syndrome) or as a part of McCune–
Albright syndrome [2,9-13].
Here we report a case of a 44-year-old woman with
myxoma located in her right deltoid muscle and aim to* Correspondence: bahattinkemah.md@gmail.com
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radiological and pathological data.
Case presentation
A 44-year-old Turkish woman presented to our clinic
with the complaint of a 3-year history of a slow growing
palpable mass in her right shoulder. She had no other
documented or reported condition.
Her physical examination revealed a palpable, mobile,
painless, partially fluctuating mass, 5×5cm in size, in her
deltoid muscle, extending to the lower lateral part of her
right shoulder and proximal lateral part of her right
arm.
Magnetic resonance imaging (MRI) revealed a lobular
contoured mass lesion, cystic in nature and measuring
34×23×37mm at its largest that was located caudal to
the lateral compartment of her deltoid muscle and an
interstitial edema in the adjacent deltoid muscle (Figure 1).
A complete blood count, biochemical and other laboratory
tests revealed normal values.
During her surgical operation, the mass was ap-
proached via a longitudinal incision over the mass in the
deltoid area of her right shoulder, sensory neural bran-
ches of the axillary nerve were preserved, and the en-
capsulated gelatinous mass 4×5cm in size was easily
separated from the muscle tissue and then excised. ALtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Appearance of the mass on T2-weighted magnetic resonance imaging sections. A) In axial section; B) in coronal section.
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vealed a nodular lesion cream-beige in color, 2.5×2.5×3cm
in size and capsular in appearance that was adjacent to
the deltoid muscle. The sectioned surface of the mass was
pink-beige in color and solid bright myxoid in appearance.
The surgical margin was tumor-free.
A microscopic examination showed that the mass con-
sisted of a small number of spindle or stellate cells, a
small number of vessels, thin collagen fibers and a small
number of loose reticular fibers embedded in an abundant
myxoid stroma (Figure 2). The cells had a small, pyk-
notic slightly hyperchromatic nucleus and scanty cyto-
plasm. Some presented multiple stellate-shaped cytoplasmicFigure 2 Tumor lesion with a small number of spindle or
stellate cells, a small number of vessels, and abundant thin
collagen fibers (hematoxylin and eosin ×100).extensions. Cellular pleomorphism, cellularity and vas-
cularity were low. There was no mitosis, necrosis or cystic
degeneration. At the periphery of the lesion, the skeletal
muscle adjacent to the tumor was atrophic with inter-
spersed edema fluid or infiltrated tumor cells (Figures 3
and 4).
An immunohistochemical examination of the mass
showed diffuse positivity for vimentin in tumor cells
(Figure 5), focal and weak positivity for CD34 in per-
ipheral regions and was negative for S-100. The Ki-67
proliferation index was less than 1%. In the light of
pathological data obtained, the mass was concluded to
be intramuscular myxoma (Figure 6).Figure 3 At the periphery of the lesion, the skeletal muscle
adjacent to the tumor is atrophic. Tumor infiltration of muscle
fibers can be monitored (hematoxylin and eosin ×200).
Figure 4 Appearance of the infiltrating tumor with atrophic
surrounding muscle fibers at higher magnification.
Figure 6 Immunohistochemical Ki-67 proliferation index is less
than 1% in tumor cells (Ki-67 ×200).
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Myxoma is a benign soft tissue tumor of unknown origin
[1]. It may originate from fibroblasts that are insuffi-
ciently differentiated and thus unable to synthesize colla-
gen or it may originate from mesenchymal stem cells
[9,14]. It was first described by Virchow in 1863 as a
benign tumor similar to mucous tissue of the umbilical
cord [15]. It was described as a mesenchymal neoplasm
composed of undifferentiated stellate cells embedded in
myxoid stroma containing weak reticular fibers in 1948
by Stout [1]. The etiology of myxomas remains elusive.Figure 5 Immunohistochemical positivity in tumor cells
(vimentin ×200).Some authors suggest that the etiology of myxomas may
be traumatic [16]. One of the theories on their etiology
is the growth of polysaccharide-producing cells in the
neoplastic process [8,16,17].
Soft tissue myxomas are rare [1]. Extracardiac myx-
omas most commonly occur in the head and skin tissue.
Enzinger, in 1965, identified characteristic properties of
a myxoma removed from intramuscular tissue, and de-
scribed it as intramuscular myxoma [8].
Intramuscular myxomas can occur in the muscles of
the thigh, buttocks, shoulder and upper extremities [9].
Intramuscular myxomas primarily affect patients be-
tween 40 and 70 years of age, with female predominance
[4-7]. They usually follow an asymptomatic course and
the most common clinical finding is a slow growing mass
[4,6-8,16,18]. In the presence of an association of mul-
tiple intramuscular myxomas with fibrous dysplasia,
Mazabraud syndrome (multiple intramuscular myxomas
and fibrous dysplasia) or McCune–Albright syndrome
(multiple intramuscular myxomas and polyostotic fibrous
dysplasia, café-au-lait stains, endocrine hyperfunction)
should be considered [2,9-14,19-22]. The case presented
here had a single myxoma with no bone pathology.
On clinical examination, intramuscular myxoma pre-
sents as a painless, palpable mass. The clinical pattern var-
ies depending on the size and site of the mass [14,23].
A radiograph reveals a nonspecific mass with no calci-
fication. On ultrasonography, it appears as cystic lesions
with echogenicity in normal muscle tissue [24]. On com-
puted tomography, it has a homogenous appearance se-
parating from the muscle tissue, similar to that of a cyst
or low density mass [25]. The most important radiologic
examination used for the mass is MRI. Intramuscular
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on T1-weighted sections, and as a hyperintense mass
on T2-weighted sections [2,25-29]. Fat-suppressed T2
sections demonstrate increased signal intensity associ-
ated with the increased water content of myxoid matrix
[25]. Increased intensity can be detected around the
mass resembling fat on T1-weighted sections. On T2-
weighted sections, edema is observed in the surrounding
muscle tissue [2,25,26]. These MRI findings may be con-
fused with other fluid-containing lesions such as myxoid
sarcoma, hematoma, lymph nodes, cystic hygroma, cystic
teratoma and abscess. The case presented here had a lobu-
lar contoured mass lesion, cystic in nature in the deltoid
muscle. There was interstitial edema in the surrounding
tissue. Other possible lesions were borne in mind in the
differential diagnosis.
The differential diagnosis of intramuscular myxoma
includes other myxoid neoplasms and proliferative lesions
of the soft tissue [6]. Benign lesions such as myxolipoma,
myxoid neurofibroma, neurothecoma, myxochondroma
and nodular fasciitis and different types of low grade myx-
oid sarcomas should also be considered. Among them,
the differential diagnosis should be established with low
grade myxofibrosarcoma, myxoid liposarcoma, extraskele-
tal myxoid chondrosarcoma and low grade fibromyxoid
sarcomas [6,9,14].
Initial diagnosis can be checked by needle biopsy [7,24]
whereas several authors use intraoperative frozen section
[30]. Differential diagnosis with benign lesions can be eas-
ily made by histological examination whereas it is difficult
to make differential diagnosis by imaging techniques due
to myxoid stroma inside myxomas [31]. In our case, an
excisional biopsy was planned and the mass was excised at
the surgical margin and a histopathological examination
was performed.
There are transition zones between hypocellular myxoid
areas and fat tissues in myxolipoma. Myxoid liposar-
coma includes atypical lipoblasts and characteristic dif-
fuse plexiform capillary network. Myxomas do not contain
lipoblasts and have poor vascularity. Myxolipomas and
liposarcomas stain positive for S-100 [19].
Neurofibroma cells display a greater degree of orienta-
tion whereas the vascularity is more prominent and they
contain abundant collagen fibers. Some areas show positive
staining for S-100. Neurothecomas contain prominent lob-
ules separated by fibrous bands. Lobules consist of myxoid
and cellular areas and stain positive for S-100 [19].
Myxochondromas contain lobular patterns with more
cellular chondroid cell groups among myxoid areas, which
usually stain positive for S-100. Myxoid chondrosarco-
mas present more pleomorphic, cellular and infiltrative
growth [19].
Nodular fasciitis stains positive for smooth muscle.
In myxomas, there is zonal organization or regionalheterogeneity of nodular fasciitis. Myxomas are more
hypocellular and have poor vascularity [19].
Low grade myxofibrosarcomas differ from myxomas in
being more pleomorphic and ill defined, and in having a
characteristic nodular pattern and organized vascular pat-
tern. Low grade fibromyxoid sarcomas are characterized
by contrasting myxoid and cellular fibrous areas with a
swirling, whorled pattern [19].
Treatment of solitary myxomas is marginal surgical
excision [7,9,32]. Extensive surgical resection is recom-
mended by some surgeons [23]. No metastasis, recur-
rence or malignant change has been reported with this
surgical procedure. However, recurrence has been re-
ported in a small number of patients undergoing enucle-
ation and incomplete resection [6,33]. Recurrent myxoma
with atypical localization has been reported in pa-
tients with the association of Mazabraud syndrome
and McCune–Albright syndrome [2,11,34,35].
In our case, no needle biopsy was performed and the
entire mass was removed with wide margins along with
the surrounding muscle tissue and the surgical specimen
was sent for pathological examination. Histopathological
examination revealed intramuscular myxoma. The pa-
tient’s treatment was completed with extensive surgical
excision in one session. Currently, she is at the postopera-
tive 6-month follow-up with no complaints or recurrence.
Conclusions
In conclusion, intramuscular myxoma of the deltoid mus-
cle is a very rare benign tumor. Even though imaging tech-
niques are helpful, the exact diagnosis is established by
histological examination. In the differential diagnosis, re-
active lesions, myxoid nodular fasciitis and low grade
myxoid sarcomas should be kept in mind, upon which the
treatment should be planned.
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